Quantcast

Global Healthcare Contract Research Organizations (CRO) Services Market 2020-2027 – Rising Biosimilars and Biologics Market Presents a Lucrative Growth Opportunity – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Healthcare Contract Research Organizations Services Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Service Type; Therapeutic Indication; End User; and Geography” report has been added to ResearchAndMarkets.com’s offering.

The global healthcare contract research organizations (CRO) services market is expected to reach US$ 87,859.08 million by 2027 from US$ 43,208.57 million in 2019. The market is estimated to grow with a CAGR of 9.5% from 2020 to 2027.

The increasing expenditure in R&D and outsourcing activities, and rising number of clinical trials are the major factors driving the growth of the healthcare contract research organizations (CRO) services market. However, the dearth of skilled professionals is hindering the growth of the market.

Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments.

Additionally, several companies invest extensively in R&D activities to develop different therapeutic applications with strong medical and commercial potential. According to a data published by European Federation of Pharmaceutical Industries and Associations, in 2018, Europe-based pharmaceutical companies invested about US$ 42,348.4 million for R&D.

Additionally, R&D spending by biopharmaceutical companies has increased over the years. For instance, according to a study published by Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of biopharmaceutical companies grew from US$ 49. (Read more…)6 billion in 2012 to US$ 79.6 billion in 2018. Such massive investments in R&Ds are likely to drive the contract research organization services market during the forecast period.

Contract research organizations assist the sponsor companies in terms of research, development, and commercialization of new therapeutic products, especially in pharmaceutical, biopharmaceutical, and medical device industries. Factors such as increasing cost of research and development, increasing complexity of clinical trials, and emphasis on cost optimization are compelling the companies to outsource research activities.

The global healthcare contract research organizations (CRO) services market is segmented on the basis of service type, therapeutic indication, and end user. Based on service type, the market is segmented into early phase development, laboratory services, consulting services, and clinical research services. The clinical research services segment held the largest share of the market in 2019 and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on therapeutic indication, the healthcare contract research organizations (CRO) services market is segmented into oncology, infectious diseases, immunological disorders, respiratory diseases, cardiovascular diseases, neurological disorders, and others.

On the basis of end user, the healthcare contract research organizations (CRO) services market has been segmented into medical device companies, pharmaceutical and biopharmaceutical companies, and others (academic institutes).

Key Topics Covered

1. Introduction

1.1 Scope of the Study

1.2 Report Guidance

1.3 Market Segmentation

1.3.1 Global Healthcare Contract Research Organizations (CRO) Services Market – By Service Type

1.3.2 Global Healthcare Contract Research Organizations (CRO) Services Market – By Therapeutic Indication

1.3.3 Global Healthcare Contract Research Organizations (CRO) Services Market – By End User

1.3.4 Global Healthcare Contract Research Organizations (CRO) Services Market – By Geography

2. Healthcare Contract Research Organizations (CRO) Services Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Healthcare Contract Research Organizations (CRO) Services Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East & Africa

4.2.5 South and Central America

4.3 Expert Opinion

5. Healthcare Contract Research Organizations (CRO) Services Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Expenditure in R&D and Outsourcing Activities

5.1.2 Rising Number of Clinical Trials

5.2 Market Restraints

5.2.1 Dearth of Skilled Professionals

5.3 Market Opportunities

5.3.1 Rising Biosimilars and Biologics Market

5.4 Future Trends

5.4.1 Globalization of Clinical Studies

5.5 Impact Analysis

6. Healthcare Contract Research Organizations (CRO) Services Market – Global Analysis

6.1 Global Healthcare Contract Research Organizations (CRO) Services Market Revenue Forecast and Analysis

6.2 Global Healthcare Contract Research Organizations (CRO) Services Market, By Geography – Forecast And Analysis

6.3 Market Positioning of Key Players

7. Healthcare Contract Research Organizations (CRO) Services Market Analysis – By Service Type

7.1 Overview

7.2 Healthcare Contract Research Organizations (CRO) Services Market Revenue Share, by Service Type (2019 and 2027)

7.3 Early Phase Development

7.4 Laboratory Services

7.5 Consulting Services

7.6 Clinical Research Services

8. Healthcare Contract Research Organizations (CRO) Services Market – By Therapeutic Application

8.1 Overview

8.2 Healthcare Contract Research Organizations (CRO) Services Market Share, by Therapeutic Application, 2019 and 2027 (%)

8.3 Oncology

8.4 Infectious Diseases

8.5 Cardiovascular Disease

8.6 Respiratory Diseases

8.7 Neurological Disorders

8.8 Others

9. Global Healthcare Contract Research Organizations (CRO) Services Market Analysis – by End User

9.1 Overview

9.2 Global Healthcare Contract Research Organizations (CRO) Services Market, By End User 2019 & 2027 (%)

9.3 Pharmaceutical and Biopharmaceutical Companies

9.4 Pharmaceutical and Biopharmaceutical Companies: Healthcare Contract Research Organizations (CRO) Services Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Medical Device Companies

9.6 Medical Device Companies: Healthcare Contract Research Organizations (CRO) Services Market – Revenue and Forecast to 2027 (US$ Million)

9.7 Others (Academic Institutes)

9.8 Others (Academic Institutes): Healthcare Contract Research Organizations (CRO) Services Market – Revenue and Forecast to 2027 (US$ Million)

Companies Mentioned

  • Charles River Laboratories Inc.
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Parexel International Corporation
  • Icon plc
  • Pra Health Sciences
  • Syneos Health
  • Medpace
  • Wuxi Apptec
  • PPD Inc.

For more information about this report visit https://www.researchandmarkets.com/r/xd0223

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Global Healthcare Contract Research Organizations (CRO) Services Market 2020-2027 – Rising Biosimilars and Biologics Market Presents a Lucrative Growth Opportunity – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Healthcare Contract Research Organizations Services Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Service Type; Therapeutic Indication; End User; and Geography” report has been added to ResearchAndMarkets.com’s offering.

The global healthcare contract research organizations (CRO) services market is expected to reach US$ 87,859.08 million by 2027 from US$ 43,208.57 million in 2019. The market is estimated to grow with a CAGR of 9.5% from 2020 to 2027.

The increasing expenditure in R&D and outsourcing activities, and rising number of clinical trials are the major factors driving the growth of the healthcare contract research organizations (CRO) services market. However, the dearth of skilled professionals is hindering the growth of the market.

Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments.

Additionally, several companies invest extensively in R&D activities to develop different therapeutic applications with strong medical and commercial potential. According to a data published by European Federation of Pharmaceutical Industries and Associations, in 2018, Europe-based pharmaceutical companies invested about US$ 42,348.4 million for R&D.

Additionally, R&D spending by biopharmaceutical companies has increased over the years. For instance, according to a study published by Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of biopharmaceutical companies grew from US$ 49. (Read more…)6 billion in 2012 to US$ 79.6 billion in 2018. Such massive investments in R&Ds are likely to drive the contract research organization services market during the forecast period.

Contract research organizations assist the sponsor companies in terms of research, development, and commercialization of new therapeutic products, especially in pharmaceutical, biopharmaceutical, and medical device industries. Factors such as increasing cost of research and development, increasing complexity of clinical trials, and emphasis on cost optimization are compelling the companies to outsource research activities.

The global healthcare contract research organizations (CRO) services market is segmented on the basis of service type, therapeutic indication, and end user. Based on service type, the market is segmented into early phase development, laboratory services, consulting services, and clinical research services. The clinical research services segment held the largest share of the market in 2019 and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on therapeutic indication, the healthcare contract research organizations (CRO) services market is segmented into oncology, infectious diseases, immunological disorders, respiratory diseases, cardiovascular diseases, neurological disorders, and others.

On the basis of end user, the healthcare contract research organizations (CRO) services market has been segmented into medical device companies, pharmaceutical and biopharmaceutical companies, and others (academic institutes).

Key Topics Covered

1. Introduction

1.1 Scope of the Study

1.2 Report Guidance

1.3 Market Segmentation

1.3.1 Global Healthcare Contract Research Organizations (CRO) Services Market – By Service Type

1.3.2 Global Healthcare Contract Research Organizations (CRO) Services Market – By Therapeutic Indication

1.3.3 Global Healthcare Contract Research Organizations (CRO) Services Market – By End User

1.3.4 Global Healthcare Contract Research Organizations (CRO) Services Market – By Geography

2. Healthcare Contract Research Organizations (CRO) Services Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Healthcare Contract Research Organizations (CRO) Services Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East & Africa

4.2.5 South and Central America

4.3 Expert Opinion

5. Healthcare Contract Research Organizations (CRO) Services Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Expenditure in R&D and Outsourcing Activities

5.1.2 Rising Number of Clinical Trials

5.2 Market Restraints

5.2.1 Dearth of Skilled Professionals

5.3 Market Opportunities

5.3.1 Rising Biosimilars and Biologics Market

5.4 Future Trends

5.4.1 Globalization of Clinical Studies

5.5 Impact Analysis

6. Healthcare Contract Research Organizations (CRO) Services Market – Global Analysis

6.1 Global Healthcare Contract Research Organizations (CRO) Services Market Revenue Forecast and Analysis

6.2 Global Healthcare Contract Research Organizations (CRO) Services Market, By Geography – Forecast And Analysis

6.3 Market Positioning of Key Players

7. Healthcare Contract Research Organizations (CRO) Services Market Analysis – By Service Type

7.1 Overview

7.2 Healthcare Contract Research Organizations (CRO) Services Market Revenue Share, by Service Type (2019 and 2027)

7.3 Early Phase Development

7.4 Laboratory Services

7.5 Consulting Services

7.6 Clinical Research Services

8. Healthcare Contract Research Organizations (CRO) Services Market – By Therapeutic Application

8.1 Overview

8.2 Healthcare Contract Research Organizations (CRO) Services Market Share, by Therapeutic Application, 2019 and 2027 (%)

8.3 Oncology

8.4 Infectious Diseases

8.5 Cardiovascular Disease

8.6 Respiratory Diseases

8.7 Neurological Disorders

8.8 Others

9. Global Healthcare Contract Research Organizations (CRO) Services Market Analysis – by End User

9.1 Overview

9.2 Global Healthcare Contract Research Organizations (CRO) Services Market, By End User 2019 & 2027 (%)

9.3 Pharmaceutical and Biopharmaceutical Companies

9.4 Pharmaceutical and Biopharmaceutical Companies: Healthcare Contract Research Organizations (CRO) Services Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Medical Device Companies

9.6 Medical Device Companies: Healthcare Contract Research Organizations (CRO) Services Market – Revenue and Forecast to 2027 (US$ Million)

9.7 Others (Academic Institutes)

9.8 Others (Academic Institutes): Healthcare Contract Research Organizations (CRO) Services Market – Revenue and Forecast to 2027 (US$ Million)

Companies Mentioned

  • Charles River Laboratories Inc.
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Parexel International Corporation
  • Icon plc
  • Pra Health Sciences
  • Syneos Health
  • Medpace
  • Wuxi Apptec
  • PPD Inc.

For more information about this report visit https://www.researchandmarkets.com/r/xd0223

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Global Healthcare Contract Research Organizations (CRO) Services Market 2020-2027 – Rising Biosimilars and Biologics Market Presents a Lucrative Growth Opportunity – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Healthcare Contract Research Organizations Services Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Service Type; Therapeutic Indication; End User; and Geography” report has been added to ResearchAndMarkets.com’s offering.

The global healthcare contract research organizations (CRO) services market is expected to reach US$ 87,859.08 million by 2027 from US$ 43,208.57 million in 2019. The market is estimated to grow with a CAGR of 9.5% from 2020 to 2027.

The increasing expenditure in R&D and outsourcing activities, and rising number of clinical trials are the major factors driving the growth of the healthcare contract research organizations (CRO) services market. However, the dearth of skilled professionals is hindering the growth of the market.

Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments.

Additionally, several companies invest extensively in R&D activities to develop different therapeutic applications with strong medical and commercial potential. According to a data published by European Federation of Pharmaceutical Industries and Associations, in 2018, Europe-based pharmaceutical companies invested about US$ 42,348.4 million for R&D.

Additionally, R&D spending by biopharmaceutical companies has increased over the years. For instance, according to a study published by Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of biopharmaceutical companies grew from US$ 49. (Read more…)6 billion in 2012 to US$ 79.6 billion in 2018. Such massive investments in R&Ds are likely to drive the contract research organization services market during the forecast period.

Contract research organizations assist the sponsor companies in terms of research, development, and commercialization of new therapeutic products, especially in pharmaceutical, biopharmaceutical, and medical device industries. Factors such as increasing cost of research and development, increasing complexity of clinical trials, and emphasis on cost optimization are compelling the companies to outsource research activities.

The global healthcare contract research organizations (CRO) services market is segmented on the basis of service type, therapeutic indication, and end user. Based on service type, the market is segmented into early phase development, laboratory services, consulting services, and clinical research services. The clinical research services segment held the largest share of the market in 2019 and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on therapeutic indication, the healthcare contract research organizations (CRO) services market is segmented into oncology, infectious diseases, immunological disorders, respiratory diseases, cardiovascular diseases, neurological disorders, and others.

On the basis of end user, the healthcare contract research organizations (CRO) services market has been segmented into medical device companies, pharmaceutical and biopharmaceutical companies, and others (academic institutes).

Key Topics Covered

1. Introduction

1.1 Scope of the Study

1.2 Report Guidance

1.3 Market Segmentation

1.3.1 Global Healthcare Contract Research Organizations (CRO) Services Market – By Service Type

1.3.2 Global Healthcare Contract Research Organizations (CRO) Services Market – By Therapeutic Indication

1.3.3 Global Healthcare Contract Research Organizations (CRO) Services Market – By End User

1.3.4 Global Healthcare Contract Research Organizations (CRO) Services Market – By Geography

2. Healthcare Contract Research Organizations (CRO) Services Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Healthcare Contract Research Organizations (CRO) Services Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East & Africa

4.2.5 South and Central America

4.3 Expert Opinion

5. Healthcare Contract Research Organizations (CRO) Services Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Expenditure in R&D and Outsourcing Activities

5.1.2 Rising Number of Clinical Trials

5.2 Market Restraints

5.2.1 Dearth of Skilled Professionals

5.3 Market Opportunities

5.3.1 Rising Biosimilars and Biologics Market

5.4 Future Trends

5.4.1 Globalization of Clinical Studies

5.5 Impact Analysis

6. Healthcare Contract Research Organizations (CRO) Services Market – Global Analysis

6.1 Global Healthcare Contract Research Organizations (CRO) Services Market Revenue Forecast and Analysis

6.2 Global Healthcare Contract Research Organizations (CRO) Services Market, By Geography – Forecast And Analysis

6.3 Market Positioning of Key Players

7. Healthcare Contract Research Organizations (CRO) Services Market Analysis – By Service Type

7.1 Overview

7.2 Healthcare Contract Research Organizations (CRO) Services Market Revenue Share, by Service Type (2019 and 2027)

7.3 Early Phase Development

7.4 Laboratory Services

7.5 Consulting Services

7.6 Clinical Research Services

8. Healthcare Contract Research Organizations (CRO) Services Market – By Therapeutic Application

8.1 Overview

8.2 Healthcare Contract Research Organizations (CRO) Services Market Share, by Therapeutic Application, 2019 and 2027 (%)

8.3 Oncology

8.4 Infectious Diseases

8.5 Cardiovascular Disease

8.6 Respiratory Diseases

8.7 Neurological Disorders

8.8 Others

9. Global Healthcare Contract Research Organizations (CRO) Services Market Analysis – by End User

9.1 Overview

9.2 Global Healthcare Contract Research Organizations (CRO) Services Market, By End User 2019 & 2027 (%)

9.3 Pharmaceutical and Biopharmaceutical Companies

9.4 Pharmaceutical and Biopharmaceutical Companies: Healthcare Contract Research Organizations (CRO) Services Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Medical Device Companies

9.6 Medical Device Companies: Healthcare Contract Research Organizations (CRO) Services Market – Revenue and Forecast to 2027 (US$ Million)

9.7 Others (Academic Institutes)

9.8 Others (Academic Institutes): Healthcare Contract Research Organizations (CRO) Services Market – Revenue and Forecast to 2027 (US$ Million)

Companies Mentioned

  • Charles River Laboratories Inc.
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Parexel International Corporation
  • Icon plc
  • Pra Health Sciences
  • Syneos Health
  • Medpace
  • Wuxi Apptec
  • PPD Inc.

For more information about this report visit https://www.researchandmarkets.com/r/xd0223

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.